Junshi Biosciences experiments with $414m HK IPO
Shanghai Junshi Biosciences has kicked off bookbuilding for its potential HK$3.24bn ($414.4m) IPO.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: